galactosamine has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burlingham, WJ; Conklin, R; Fondy, TP; Simon, P | 1 |
1 other study(ies) available for galactosamine and Leukemia L 1210
| Article | Year |
|---|---|
N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice.
Topics: Acetylgalactosamine; Acetylglucosamine; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Survival; Cells, Cultured; Female; Galactosamine; Glucosamine; Immunity; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Structure-Activity Relationship | 1979 |